These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 8826565

  • 1. Dual calcium-channel blocker therapy in the treatment of hypertension.
    Saseen JJ, Carter BL.
    Ann Pharmacother; 1996; 30(7-8):802-10. PubMed ID: 8826565
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension.
    Flynn JT, Pasko DA.
    Pediatr Nephrol; 2000 Dec; 15(3-4):302-16. PubMed ID: 11149130
    [Abstract] [Full Text] [Related]

  • 4. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
    Opie LH, Yusuf S, Kübler W.
    Prog Cardiovasc Dis; 2000 Dec; 43(2):171-96. PubMed ID: 11014332
    [Abstract] [Full Text] [Related]

  • 5. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
    Opie LH.
    Am J Hypertens; 1997 May; 10(5 Pt 1):565-77. PubMed ID: 9160770
    [Abstract] [Full Text] [Related]

  • 6. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
    Bulpitt CJ, Palmer AJ, Beevers DG, Coles EC, Ledingham JG, Petrie JC, Webster J.
    J Hum Hypertens; 1997 Apr; 11(4):205-11. PubMed ID: 9185024
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.
    Makarounas-Kirchmann K, Glover-Koudounas S, Ferrari P.
    Clin Ther; 2009 Aug; 31(8):1652-63. PubMed ID: 19808126
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Update on calcium-channel blocking agents.
    Talbert RL, Bussey HI.
    Clin Pharm; 1983 Aug; 2(5):403-16. PubMed ID: 6354566
    [Abstract] [Full Text] [Related]

  • 13. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL.
    J Am Pharm Assoc (2003); 2010 Aug; 50(5):e116-25. PubMed ID: 20833609
    [Abstract] [Full Text] [Related]

  • 14. Calcium channel blockers: monotherapy and dual therapy considerations in the treatment of hypertension.
    Sica DA.
    Am J Cardiovasc Drugs; 2007 Aug; 7 Suppl 1():1-3. PubMed ID: 19847946
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.
    Oparil S, Weber M.
    Postgrad Med; 2009 Mar; 121(2):25-39. PubMed ID: 19332960
    [Abstract] [Full Text] [Related]

  • 16. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
    Yang Y, Wei RB, Xing Y, Tang L, Zheng XY, Wang ZC, Gao YW, Li MX, Chen XM.
    Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
    [Abstract] [Full Text] [Related]

  • 17. Calcium channel blockers in cardiovascular pharmacotherapy.
    Godfraind T.
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Extracorporeal treatment for calcium channel blocker poisoning: systematic review and recommendations from the EXTRIP workgroup.
    Wong A, Hoffman RS, Walsh SJ, Roberts DM, Gosselin S, Bunchman TE, Kebede S, Lavergne V, Ghannoum M, EXTRIP workgroup.
    Clin Toxicol (Phila); 2021 May; 59(5):361-375. PubMed ID: 33555964
    [Abstract] [Full Text] [Related]

  • 20. High blood pressure and calcium antagonism.
    Palma-Gámiz JL.
    Cardiology; 1997 May; 88 Suppl 1():39-46. PubMed ID: 9118167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.